Abstract
Treatment of hepatocellular carcinoma (HCC) depends on disease staging, which is usually performed according to the Barcelona Clinic Liver Cancer (BCLC) system. Although the BCLC system is recommended in the guidelines from the European Association for the Study of the Liver,1 the American Association for the Study of Liver Diseases,2 and the European Society for Medical Oncology3, its treatment recommendations for intermediate and advanced HCC are inconsistent with the literature.
This article is protected by copyright. All rights reserved.
https://ift.tt/2GgZYSC
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.